Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > Priest who volunteered for COVID-19 vaccine trial dies

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Dec 03, 2020 10:27pm

93 Views

Post# 32034692

RE:Priest who volunteered for COVID-19 vaccine trial dies

Can we assume from your heavy use of highlight, bold, and underlines that you are trying to imply the vaccine was the cause of the heart attack? Is that a full medical autopsy on your part?

<< Previous

Bullboard Posts

Next >>

Three stocks with strong income statements to buy right now